𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer

✍ Scribed by Jürgen Pannek; Harry G. Rittenhouse; Cindy L. Evans; Judith A. Finlay; Debra J. Bruzek; Jennifer L. Cox; Daniel W. Chan; Eric N.P. Subong; Alan W. Partin

Book ID
119486960
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
769 KB
Volume
50
Category
Article
ISSN
0090-4295

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular forms of prostate-specific ant
Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen <4 μg/L: Are they useful tools for early detection and screening of prostate cancer?
✍ Klaus Jung; Carsten Stephan; Ulrike Elgeti; Michael Lein; Brigitte Brux; Glen Kr 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 149 KB 👁 1 views

Molecular forms of prostate-specific antigen (PSA) improve the differentiation between benign prostatic hyperplasia (BPH) and prostate cancer (PCa) in men with total PSA concentrations between 4 and 10 microg/l. To evaluate the diagnostic utility of free PSA (fPSA) and complexed PSA forms for identi

Different proportions of various prostat
Different proportions of various prostate-specific antigen (PSA) and human kallikrein 2 (hK2) forms are present in noninduced and androgen-induced LNCaP cells
✍ Abhay Kumar; Stephen D. Mikolajczyk; Timothy M. Hill; Lisa S. Millar; Mohammad S 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB

## BACKGROUND. Human prostate-specific antigen (PSA) and human kallikrein 2 (hK2) are expressed primarily by prostate epithelial cells. PSA and hK2 both exist as free protein and complexed with protease inhibitors (e.g., ␣1-antichymotrypsin, ACT) in serum. The expression of PSA and hK2 in LNCaP ce